Schmerzlose, rotviolette Hautflecken unter Immunsuppression. [Painless, red-violet skin lesions during immunosuppression]

Détails

ID Serval
serval:BIB_C1247A377594
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Schmerzlose, rotviolette Hautflecken unter Immunsuppression. [Painless, red-violet skin lesions during immunosuppression]
Périodique
Therapeutische Umschau
Auteur⸱e⸱s
Pfister  M., Vogt  B.
ISSN
0040-5930 (Print)
Statut éditorial
Publié
Date de publication
09/1998
Volume
55
Numéro
9
Pages
583-5
Notes
Case Reports
English Abstract
Journal Article --- Old month value: Sep
Résumé
A patient with painless, bluish-red skin lesions under immunosuppressive treatment for kidney transplantation is presented. The clinical and histological diagnosis was Kaposi's sarcoma. This is a rare but serious complication in the immunocompromised patient. Human Herpes virus 8 (HHV 8) was recently found in the lesions from patients with Kaposi's sarcoma. This supports the important role of immunosuppression in the development of this tumor. Therapy consists of reduction or stopping of the immunosuppressive drugs which is usually followed by reduction in tumor mass. Local skin tumors can be treated with irradiation or laser therapy. In the case of lesions of visceral organs chemotherapeutic regimens consisting of vinicristine/bleomycin are indicated. New strategies aim to reduce the virus load with antiviral drugs or to inhibit the angiogenesis of this highly vascularized tumor.
Mots-clé
Biopsy Diagnosis, Differential *Herpesvirus 8, Human/isolation & purification Humans Immunosuppressive Agents/*adverse effects/therapeutic use Kidney Transplantation/*immunology Male Middle Aged Sarcoma, Kaposi/*chemically induced/immunology/pathology Skin/pathology Skin Neoplasms/*chemically induced/immunology/pathology
Pubmed
Création de la notice
25/01/2008 13:03
Dernière modification de la notice
20/08/2019 15:35
Données d'usage